Ligand · LUO
LUO · N-(4-methoxyphenyl)-N~2~-[1-(2-methylphenyl)-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-L-alaninamide
LUO, N-(4-methoxyphenyl)-N~2~-[1-(2-methylphenyl)-4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-L-alaninamide (C22 H22 N6 O3, 418.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- LUO
- Formula
- C22 H22 N6 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
LUO in 2 structures; the first of them:
- 4GH6 · Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28 · LUO A601 · binds PHE251, HIS252, MET365, ILE403, ASN405, GLU406, LEU420, TYR424 and 5 more
- 4GH6 · Crystal structure of the PDE9A catalytic domain in complex with inhibitor 28 · LUO A601 · binds PHE251, HIS252, MET365, ILE403, ASN405, GLU406, LEU420, TYR424 and 5 more
Residues it binds most
PHE 6, ALA 6, ILE 6, VAL 6, GLN 4, GLU 4, HIS 4, LEU 4, MET 4, TYR 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.